Decoding the Language of Cells.
Q-Immune translates dynamic cellular signaling into highly accurate predictive biosignatures. By measuring native protein networks in living cells, we eliminate clinical guesswork and engineer safer, high-impact immunotherapies.
OUR APPROACH
Predicting Therapeutic Performance from a Cell’s Functional Blueprint
Standard preclinical models frequently fail to anticipate a cell therapy's true clinical performance, leaving developers blind to life-threatening toxicities like Cytokine Release Syndrome (CRS). Q-Immune closes this gap. By directly measuring dynamic protein interaction networks within living cells, we generate the high-resolution, functional data needed to move beyond traditional assumptions and accurately forecast safety and efficacy before a therapy reaches the patient.
OUR TECHNOLOGY
QMI + AI
A Predictive Engine for Next-Generation Cellular Therapies
We achieve our predictive capability by unifying our proprietary Quantitative Multiplex co-Immunoprecipitation (QMI) assay with advanced computational modeling. QMI maps native, multi-protein signaling complexes at the mesoscale without the interference of genetic tags. We translate these high-fidelity datasets into algorithmic "Network Biosignatures," successfully predicting CRS with >90% accuracy in preclinical models and allowing partners to quantitatively de-risk their pipelines.
OUR PARTNERS
We partner with leading biopharma innovators to quantitatively de-risk and accelerate the development of next-generation cellular therapies.
